Cargando…
Predicting Hemagglutinin MHC-II Ligand Analogues in Anti-TNFα Biologics: Implications for Immunogenicity of Pharmaceutical Proteins
The purpose of this study was to evaluate the extent of overlapping immunogenic peptides between three pharmaceutical biologics and influenza viruses. Clinical studies have shown that subsets of patients with rheumatoid arthritis (RA) develop anti-drug antibodies towards anti-TNFα biologics. We post...
Autores principales: | Andrick, Benjamin J., Schwab, Alexandra I., Cauley, Brianna, O’Donnell, Lauren A., Meng, Wilson S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536234/ https://www.ncbi.nlm.nih.gov/pubmed/26270649 http://dx.doi.org/10.1371/journal.pone.0135451 |
Ejemplares similares
-
Altering the Immunogenicity of Hemagglutinin Immunogens by Hyperglycosylation and Disulfide Stabilization
por: Thornlow, Dana N., et al.
Publicado: (2021) -
Enhanced Immunogenicity of Stabilized Trimeric Soluble Influenza Hemagglutinin
por: Weldon, William C., et al.
Publicado: (2010) -
Molecular Dynamics of Sialic Acid Analogues and their Interaction with Influenza Hemagglutinin
por: Blessia, T. Femlin, et al.
Publicado: (2010) -
On the role of the transmembrane anchor sequence of influenza hemagglutinin in target cell recognition by class I MHC-restricted, hemagglutinin-specific cytolytic T lymphocytes
Publicado: (1987) -
Immunogenicity of TNF-Inhibitors
por: Atiqi, Sadaf, et al.
Publicado: (2020)